McCarthy, J. Markham // Am J Respir Crit Care Med. - 2000. - V. 161(6). -
P. 2019-25.
186.
RamirezVenegas A. Salmeterol reduces dyspnoea and improves lunu
function in patients with COPD / A. RamirezVenegas., J. Ward., T. Lentine ;
Chest. - 1997. V. 112. - P. 335-340.
187.
Rosenthal JB. Tolerance and efficacy of antihypertensive therapy by ci-
lazapril in common practice / J.B. Rosenthal, U. // Osowski Cardiology -
1996. - V. S7. - P. 54-9.
188.
Saadjian A. Nifedipine inhibits the effects ol'almitrine in patients suf
fering from pulmonary artery hipertension secondaryto chronic obstructive
pulmonary diseases / A. Saadjian, F. Philip-Joet, Barret // J. Cardiovasc.
Pharmacol. - 1993. - V. 21. - P. 797-803.
189.
Sajkov D. A comparison of two long-actingvasoselective calcium anta
gonists in pulmonary hypertension secondarytoCOPD / D. Sajkov, T Wang.,
P.A. Frith // Chest. - 1997. - V. I I I . - P. 1622-1630.
190.
Scribner AW. The effect of angiotensin-converting enzyme inhibition
on endothelial function and oxidant stress / A.W. Scribner, J Loscalzo, C.
Napoli // Eur J Pharmacol. - 2003. V. 48. - P. 95-9.
191.
Sebastian J. Young M.Angiotensin convertingenzyme inhibitors and
couth / J. Sebastian, W. McKinney, J. Kaufman // Chest. - 1991. - V. 99. - P.
36-39.
192.
Sestini P. Shortacting (32-agonists for stable COPD (Cochran Review).
In: The Cochran Library / P. Sestini. - Issue 4, 2001. Oxford Update Software.
193.
Shannon M. Lifethreatening events after theophylline overdose: a
1Oyearprispective analysis / M. Shannon // Arch Intern Med. - 1999. V. 159.
P. 989-994.
194.
Siafakas N.M. Optimal assessment and management of chronic ob
structive pulmonary disease (COPD) / N.M. Siafakas, P.Vermeire, N.B. Pride
// Eur Respir J. - 1995. - V. 8. - P. 1398-1420.
138
